John Clancy

5.8k total citations
149 papers, 3.4k citations indexed

About

John Clancy is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Clinical Psychology. According to data from OpenAlex, John Clancy has authored 149 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 22 papers in Physiology and 16 papers in Clinical Psychology. Recurrent topics in John Clancy's work include Cystic Fibrosis Research Advances (52 papers), Neonatal Respiratory Health Research (23 papers) and Asthma and respiratory diseases (16 papers). John Clancy is often cited by papers focused on Cystic Fibrosis Research Advances (52 papers), Neonatal Respiratory Health Research (23 papers) and Asthma and respiratory diseases (16 papers). John Clancy collaborates with scholars based in United States, United Kingdom and Netherlands. John Clancy's co-authors include Andrew McVicar, Russell Noyes, Rhonda D. Szczesniak, R Noyes, Steven M. Rowe, James Reich, Thomas W. O’Gorman, George Winokur, David M. Bird and Zsuzsa Bebők and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

John Clancy

135 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Clancy United States 36 1.3k 549 474 469 395 149 3.4k
Motomu Suga Japan 34 1.1k 0.8× 668 1.2× 577 1.2× 526 1.1× 233 0.6× 92 4.3k
Marian Willinger United States 38 1.4k 1.1× 288 0.5× 423 0.9× 219 0.5× 497 1.3× 82 6.1k
Barbara Sperner‐Unterweger Austria 42 510 0.4× 515 0.9× 555 1.2× 684 1.5× 306 0.8× 152 5.0k
Arnon Elizur Israel 35 665 0.5× 740 1.3× 299 0.6× 403 0.9× 246 0.6× 156 3.5k
Wenhua Liu China 32 485 0.4× 253 0.5× 385 0.8× 357 0.8× 229 0.6× 146 4.1k
Debra Lyon United States 34 575 0.4× 721 1.3× 471 1.0× 503 1.1× 213 0.5× 156 3.5k
Steven J. Verhulst United States 33 653 0.5× 559 1.0× 173 0.4× 381 0.8× 173 0.4× 100 4.0k
Manfred Rauh Germany 45 1.3k 1.0× 1.2k 2.2× 1.8k 3.8× 240 0.5× 226 0.6× 189 6.8k
Albert M. Li Hong Kong 39 1.1k 0.9× 1.7k 3.0× 619 1.3× 200 0.4× 198 0.5× 110 4.3k
Masayo Kojima Japan 38 271 0.2× 560 1.0× 532 1.1× 714 1.5× 436 1.1× 150 4.5k

Countries citing papers authored by John Clancy

Since Specialization
Citations

This map shows the geographic impact of John Clancy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Clancy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Clancy more than expected).

Fields of papers citing papers by John Clancy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Clancy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Clancy. The network helps show where John Clancy may publish in the future.

Co-authorship network of co-authors of John Clancy

This figure shows the co-authorship network connecting the top 25 collaborators of John Clancy. A scholar is included among the top collaborators of John Clancy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Clancy. John Clancy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Gómez, Ignacio, Jemma L. Webber, John Clancy, et al.. (2025). Targeted cell interconversions reveal inner hair cell control of organ of Corti cytoarchitecture. Science Advances. 11(44). eadz3944–eadz3944.
2.
Morgan, Sarah J., George M. Solomon, John Clancy, et al.. (2024). Elexacaftor/tezacaftor/ivacaftor’s effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment. Journal of Clinical Investigation. 134(20). 15 indexed citations
3.
Sangiorgi, Luca, et al.. (2024). Project SATURN– a real-world evidence data collaboration with existing European datasets in Osteogenesis Imperfecta to support future therapies. Orphanet Journal of Rare Diseases. 19(1). 184–184. 1 indexed citations
4.
Morgan, Sarah J., Ni Wang, Stephen J. Salipante, et al.. (2023). 64 Sputum density of Aspergillus fumigatus markedly declines after treatment with elexacaftor-tezacaftor-ivacaftor. Journal of Cystic Fibrosis. 22. S34–S35. 1 indexed citations
5.
6.
Brokamp, Cole, Eleni‐Rosalina Andrinopoulou, Judith W. Dexheimer, et al.. (2023). Built environment factors predictive of early rapid lung function decline in cystic fibrosis. Pediatric Pulmonology. 58(5). 1501–1513. 5 indexed citations
7.
Garcı́a-Añoveros, Jaime, John Clancy, Ignacio García‐Gómez, et al.. (2022). Tbx2 is a master regulator of inner versus outer hair cell differentiation. Nature. 605(7909). 298–303. 51 indexed citations
8.
Blankenship, Chelsea M., Lisa L. Hunter, M. Patrick Feeney, et al.. (2021). Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort. American Journal of Audiology. 30(3S). 834–853. 16 indexed citations
9.
Pratt, Jesse, et al.. (2021). An Animated Functional Data Analysis Interface to Cluster Rapid Lung Function Decline and Enhance Center-Level Care in Cystic Fibrosis. Journal of Healthcare Engineering. 2021. 1–13. 3 indexed citations
10.
Sivaganesan, Siva, et al.. (2021). Bayesian regularization for a nonstationary Gaussian linear mixed effects model. Statistics in Medicine. 41(4). 681–697. 7 indexed citations
11.
Brokamp, Cole, Rui Huang, Eleni‐Rosalina Andrinopoulou, et al.. (2021). Seasonality, mediation and comparison (SMAC) methods to identify influences on lung function decline. MethodsX. 8. 101313–101313. 1 indexed citations
12.
Szczesniak, Rhonda D., Leo L. Duan, Dan Li, et al.. (2020). Data driven decision making to characterize clinical personas of parents of children with cystic fibrosis: a mixed methods study. BMC Pulmonary Medicine. 20(1). 174–174. 1 indexed citations
13.
Mayer-Hamblett, Nicole, Christopher H. Goss, George Retsch‐Bogart, et al.. (2020). The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network. Journal of Cystic Fibrosis. 20(2). 195–197. 7 indexed citations
14.
Andrinopoulou, Eleni‐Rosalina, John Clancy, & Rhonda D. Szczesniak. (2020). Multivariate joint modeling to identify markers of growth and lung function decline that predict cystic fibrosis pulmonary exacerbation onset. BMC Pulmonary Medicine. 20(1). 142–142. 7 indexed citations
15.
Wolfe, Chris, Ruth H. Keogh, John Pestian, et al.. (2020). Cystic Fibrosis Point of Personalized Detection (CFPOPD): An Interactive Web Application. JMIR Medical Informatics. 8(12). e23530–e23530. 4 indexed citations
16.
Szczesniak, Rhonda D., Cole Brokamp, Ruth H. Keogh, et al.. (2019). Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression. Statistics in Medicine. 39(6). 740–756. 17 indexed citations
17.
Szczesniak, Rhonda D., et al.. (2018). Improving Detection of Rapid Cystic Fibrosis Disease Progression–Early Translation of a Predictive Algorithm Into a Point-of-Care Tool. IEEE Journal of Translational Engineering in Health and Medicine. 7. 1–8. 12 indexed citations
18.
Duan, Leo L., Xia Wang, John Clancy, & Rhonda D. Szczesniak. (2018). Joint hierarchical Gaussian process model with application to personalized prediction in medical monitoring. Stat. 7(1). 8 indexed citations
19.
Li, Dan, Ruth H. Keogh, John Clancy, & Rhonda D. Szczesniak. (2017). Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosis. Emerging Themes in Epidemiology. 14(1). 13–13. 9 indexed citations
20.
Clancy, John & Andrew McVicar. (1998). Neurophysiology of pain.. PubMed. 7(10). 19, 22–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motomu Suga Breakdown of academic impact, for papers by Marian Willinger Breakdown of academic impact, for papers by Barbara Sperner‐Unterweger Breakdown of academic impact, for papers by Arnon Elizur Breakdown of academic impact, for papers by Wenhua Liu Breakdown of academic impact, for papers by Debra Lyon Breakdown of academic impact, for papers by Steven J. Verhulst Breakdown of academic impact, for papers by Manfred Rauh Breakdown of academic impact, for papers by Albert M. Li Breakdown of academic impact, for papers by Masayo Kojima
Rankless by CCL
2026